| Literature DB >> 34983670 |
Yan-Yu Zhang1, Yu-Feng Huang1, Jie Liang1, Hua Zhou2,3,4.
Abstract
BACKGROUND: Up-and-down procedure (UDP) was recommended to replace traditional acute toxicity methods. However, it was limited due to the long experimental period (20-42 days). To improve UDP, an improved UDP method (iUDP) was developed by shortening observation time between sequence dosages. The aim of this study was to test the reliability of iUDP to provide a reliable method for the acute toxicity measurement of valuable or minor amount compounds.Entities:
Keywords: Acute toxicity; Berberine hydrochloride; Improved up-and-down procedure; Median lethal dose; Modified Karber method; Nicotine; Sinomenine hydrochloride
Mesh:
Substances:
Year: 2022 PMID: 34983670 PMCID: PMC8725450 DOI: 10.1186/s40360-021-00541-7
Source DB: PubMed Journal: BMC Pharmacol Toxicol ISSN: 2050-6511 Impact factor: 2.483
Comparison between UDP and traditional acute toxicity test methods
| Method | Mice | Time (day) | Precision |
|---|---|---|---|
| UDP [ | 4 ~ 15 | 20 ~ 42 | 95% CI was wide, imprecise |
| Traditional acute toxicity methods | |||
| Bliss method [ | ~ 80 | 14 | 95% CI was narrow, precise |
| mKM [ | ~ 80 | 14 | 95% CI was narrow, precise |
Fig. 1Percentage of UDP used in acute toxicity tests from January 2008 to August 2021
Lethality and signs of toxicity in mice administered with nicotine tested by iUDP
| Seq. | Dosage (mg/kg) | Δm (g) | Short-term outcome | Symptoms | Pathology |
|---|---|---|---|---|---|
| 1 | 12.6 | 1.1 | O | Convulsive, weakness, recovered after 2 h | No visible alterations were found in organs and tissues |
| 2 | 20 | 1.5 | O | Violently convulsive, recovered after 2 h | Spleen was enlarged and congested |
| 3 | 32 | 1.4 | O | Violently convulsive, weakness, recovered after 6 h | Lung was enlarged and congested |
| 4 | 50 | 0.9 | X | Violently convulsive, dead after 5 min | Heart and lung were enlarged |
| 5 | 32 | 1.1 | O | Violently convulsive, weakness, recovered after 6 h | Heart and lung were markedly enlarged |
| 6 | 50 | 1.7 | X | Violently convulsive, dead after 10 min | Heart, liver and lung were enlarged |
| 7 | 32 | 1.4 | X | Violently convulsive, dead after 5 min | Heart, liver and lung were enlarged |
| Stop criteria met: 3 reversals in 5 tests | |||||
Note: The sequence of outcomes: O for alive and X for dead
Effect of nicotine on organ indexes in ICR mice by iUDP
| Dosage (mg/kg) | Heart (%) | Liver (%) | Spleen (%) | Lung (%) | Kidney (%) |
|---|---|---|---|---|---|
| 0 | 0.466 ± 0.002 | 4.800 ± 0.373 | 0.387 ± 0.079 | 0.588 ± 0.057 | 1.282 ± 0.140 |
| 12.6 | 0.491 | 4.665 | 0.370 | 0.609 | 1.248 |
| 20 | 0.485 | 4.250 | 0.381 | 0.643 | 1.185 |
| 32 | 0.474 ± 0.018 | 4.548 ± 0.505 | 0.366 ± 0.084 | 0.653 ± 0.056** | 1.170 ± 0.058 |
| 50 | 0.581 ± 0.051** | 5.123 ± 0.155 | 0.385 ± 0.063 | 0.702 ± 0.015** | 1.107 ± 0.007 |
Note: *P < 0.05 vs Normal, **P < 0.01 vs Normal
Lethality and signs of toxicity of mice administered with sinomenine hydrochloride by iUDP
| Seq. | Dosage (mg/kg) | Δm (g) | Short-term outcome | Symptoms | Pathology |
|---|---|---|---|---|---|
| 1 | 175 | 1.1 | O | Mild, shortness of breath, frightened, recovered after 2 h | No visible alterations were found in organs |
| 2 | 280 | 1.4 | O | Shortness of breath, frightened, recovered after 5 h | No visible alterations were found in organs |
| 3 | 440 | 1.8 | O | Tremor, breathlessness, and recovered after 2 h | Liver was enlarged |
| 4 | 700 | 1.3 | X | Severe tremor, weakness, dead after 30 min | Liver was enlarged |
| 5 | 440 | 1.5 | O | Mild tremor, weakness, and recovered after 2 h | Liver and kidney were enlarged |
| 6 | 700 | 0.9 | X | Severe tremor, weakness, dead after 1 h | Liver was enlarged |
| 7 | 440 | 0.9 | X | Breathlessness, tremor, and dead after 4 h | Liver and kidney were enlarged |
| Stop criteria met: 5 reversals in 6 tests | |||||
Note: The sequence of outcomes: O for alive and X for dead
Effect of sinomenine hydrochloride on organ indexes in ICR mice by iUDP
| Dosage (mg/kg) | Heart (%) | Liver (%) | Spleen (%) | Lung (%) | Kidney (%) |
|---|---|---|---|---|---|
| 0 | 0.466 ± 0.002 | 4.800 ± 0.373 | 0.387 ± 0.079 | 0.588 ± 0.057 | 1.282 ± 0.140 |
| 175 | 0.550 | 4.660 | 0.312 | 0.623 | 1.120 |
| 280 | 0.450 | 4.258 | 0.467 | 0.578 | 1.295 |
| 440 | 0.403 ± 0.012 | 4.382 ± 0.442 | 0.345 ± 0.082 | 0.519 ± 0.110 | 1.110 ± 0.035* |
| 700 | 0.315 ± 0.065** | 4.452 ± 0.486 | 0.293 ± 0.033** | 0.566 ± 0.065 | 1.005 ± 0.085** |
Note: *P < 0.05 vs Normal, **P < 0.01 vs Normal
Lethality and signs of toxicity of mice administrated with berberine hydrochloride by iUDP
| Seq. | Dosage (mg/kg) | Δm (g) | Short-term outcome | Symptoms | Pathology |
|---|---|---|---|---|---|
| 1 | 790 | 1.1 | O | Reduced activity, recovered after 2 h | No visible alterations were found in organs and tissues |
| 2 | 2500 | 1.5 | O | Reduced activity, recovered after 4.5 h | No visible alterations were found in organs and tissues |
| 3 | 5000 | 1.4 | X | Reduced activity, weakness, dead after 10 h | Liver was congested |
| 4 | 2500 | 0.9 | O | Reduced activity, recovered after 4.5 h | No visible alterations were found in organs and tissues |
| 5 | 5000 | 1.1 | X | Reduced activity, weakness, dead after 8 h | Liver was congested |
| 6 | 2500 | 1.7 | X | Reduced activity, dead after 16 h | No visible alterations were found in organs and tissues |
| 7 | 790 | 1.4 | O | Reduced activity, recovered after 1 h | No visible alterations were found in organs and tissues |
| 8 | 2500 | 1.1 | O | Reduced activity, recovered after 4 h | No visible alterations were found in organs and tissues |
| 9 | 5000 | 1.0 | X | Reduced activity, weakness, and dead after 18 h | Liver was congested |
| Stop criteria met: 3 reversals in 5 tests | |||||
Note: The sequence of outcomes: O for alive and X for dead
Effect of berberine hydrochloride on organ indexes in ICR mice by iUDP
| Dosage (mg/kg) | Heart (%) | Liver (%) | Spleen (%) | Lung (%) | Kidney (%) |
|---|---|---|---|---|---|
| 0 | 0.466 ± 0.002 | 4.800 ± 0.373 | 0.387 ± 0.079 | 0.588 ± 0.057 | 1.282 ± 0.140 |
| 790 | 0.472 ± 0.028 | 4.602 ± 0.295 | 0.363 ± 0.063 | 0.580 ± 0.097 | 1.100 ± 0.100 |
| 2500 | 0.449 ± 0.045 | 4.472 ± 0.207 | 0.427 ± 0.096 | 0.627 ± 0.108 | 1.280 ± 0.073 |
| 5000 | 0.465 ± 0.039 | 4. 503 ± 0.200 | 0.426 ± 0.041* | 0.598 ± 0.049 | 1.129 ± 0.068 |
Note: *P < 0.05 vs Normal, **P < 0.01 vs Normal
Lethality and signs of toxicity of mice administrated with nicotine by mKM
| Group | n | Dosage (mg/kg) | Morality (p) | p2 | Pathology |
|---|---|---|---|---|---|
| 1 | 10 | 16 | 0.2 | 0.04 | No visible alterations were found in other organs and tissues. |
| 2 | 10 | 20 | 0.3 | 0.09 | Liver was enlarged and congested |
| 3 | 10 | 25 | 0.7 | 0.49 | Liver was enlarged and congested |
| 4 | 10 | 31.25 | 0.8 | 0.64 | Liver and kidney were enlarged and congested |
| 5 | 10 | 39.1 | 0.9 | 0.81 | Liver and kidney were significantly enlarged and congested |
Note: The sequence of outcomes: O for alive and X for dead
Effect of different doses of nicotine on organ indexes in ICR mice by mKM
| Dosage (mg/kg) | Heart (%) | Liver (%) | Spleen (%) | Lung (%) | Kidney (%) |
|---|---|---|---|---|---|
| 0 | 0.466 ± 0.002 | 4.800 ± 0.373 | 0.387 ± 0.079 | 0.588 ± 0.057 | 1.282 ± 0.140 |
| 16 | 0.467 ± 0.023 | 4.667 ± 0.317 | 0.412 ± 0.066 | 0.603 ± 0.046 | 1.177 ± 0.075 |
| 20 | 0.482 ± 0.061 | 4.772 ± 0.476 | 0.468 ± 0.068 | 0.603 ± 0.081 | 1.220 ± 0.064 |
| 25 | 0.431 ± 0.002 | 4.825 ± 0.034 | 0.578 ± 0.154 | 0.665 ± 0.038* | 1.211 ± 0.021 |
| 31.25 | 0.437 ± 0.009 | 4.272 ± 0.363 | 0.423 ± 0.022 | 0.692 ± 0.058** | 1.187 ± 0.052 |
| 39.10 | 0.490 ± 0.041 | 4.891 ± 0.105 | 0.391 ± 0.055 | 0.700 ± 0.020** | 1.137 ± 0.09 |
Note: *P < 0.05 vs Normal, **P < 0.01 vs Normal
Lethality and signs of toxicity of mice administrated with sinomenine hydrochloride by mKM
| Group | n | Dosage (mg/kg) | Morality (p) | p2 | Pathology |
|---|---|---|---|---|---|
| 1 | 10 | 300 | 0 | 0 | No visible alterations were found in organs and tissues |
| 2 | 10 | 365 | 0.3 | 0.09 | Liver was enlarged and congested |
| 3 | 10 | 446 | 0.4 | 0.16 | Liver was enlarged and congested |
| 4 | 10 | 544 | 0.7 | 0.49 | Liver and kidney were enlarged and congested |
| 5 | 10 | 663 | 0.9 | 0.81 | Liver and kidney were significantly enlarged and congested |
Effect of different doses of sinomenine hydrochloride on organ indexes in ICR mice by mKM
| Dosage (mg/kg) | Heart (%) | Liver (%) | Spleen (%) | Lung (%) | Kidney (%) |
|---|---|---|---|---|---|
| 0 | 0.466 ± 0.002 | 4.800 ± 0.373 | 0.387 ± 0.079 | 0.588 ± 0.057 | 1.282 ± 0.140 |
| 300 | 0.494 ± 0.091 | 4.948 ± 0.500 | 0.404 ± 0.085 | 0.571 ± 0.109 | 1.217 ± 0.184 |
| 365 | 0.454 ± 0.036 | 4.925 ± 0.298 | 0.393 ± 0.063 | 0.586 ± 0.092 | 1.101 ± 0.104 |
| 446 | 0.403 ± 0.012 | 4.382 ± 0.442 | 0.335 ± 0.082 | 0.519 ± 0.110 | 1.210 ± 0.035 |
| 544 | 0.421 ± 0.037 | 3.931 ± 0.240 | 0.327 ± 0.078 | 0.543 ± 0.022 | 1.109 ± 0.110* |
| 663 | 0.345 ± 0.035** | 4.327 ± 0.248 | 0.305 ± 0.021 | 0.554 ± 0.054 | 0.973 ± 0.063** |
Note: *P < 0.05 vs Normal, **P < 0.01 vs Normal
Lethality and signs of toxicity of mice administered with berberine hydrochloride by mKM
| Group | n | Dosage (mg/kg) | Morality (p) | p2 | Pathology |
|---|---|---|---|---|---|
| 1 | 10 | 703 | 0.2 | 0.04 | No visible alterations were found in other organs and tissues |
| 2 | 10 | 1406 | 0.3 | 0.09 | No visible alterations were found in other organs and tissues |
| 3 | 10 | 2812 | 0.4 | 0.16 | No visible alterations were found in other organs and tissues |
| 4 | 10 | 5628 | 0.7 | 0.49 | Lung were enlarged |
| 5 | 10 | 11,250 | 0.9 | 0.81 | Liver and lung were enlarged, and spleen was reduced |
Effect of berberine hydrochloride on organ indexes in ICR mice by mKM
| Dosage (mg/kg) | Heart (%) | Liver (%) | Spleen (%) | Lung (%) | Kidney (%) |
|---|---|---|---|---|---|
| 0 | 0.466 ± 0.002 | 4.800 ± 0.373 | 0.387 ± 0.079 | 0.588 ± 0.057 | 1.282 ± 0.140 |
| 703 | 0.463 ± 0.018 | 5.010 ± 0.558 | 0.406 ± 0.092 | 0.553 ± 0.069 | 1.227 ± 0.203 |
| 1406 | 0.429 ± 0.028 | 4.740 ± 0.295 | 0.422 ± 0.063 | 0.645 ± 0.097 | 1.162 ± 0.100 |
| 2812 | 0.454 ± 0.017 | 4.453 ± 0.242 | 0.398 ± 0.075 | 0.667 ± 0.031 | 1.198 ± 0.131 |
| 5628 | 0.473 ± 0.046 | 4.575 ± 0.173 | 0.394 ± 0.042 | 0.625 ± 0.024 | 1.320 ± 0.073 |
| 11,250 | 0.442 ± 0.053 | 5.877 ± 0.309** | 0.288 ± 0.065** | 0.697 ± 0.090** | 1.249 ± 0.110 |
Note: *P < 0.05 vs Normal, **P < 0.01 vs Normal
Classification Criteria for Acute Toxicity [46]
| Exposure route | Category I | Category II | Category III | Category IV | Category V |
|---|---|---|---|---|---|
| Oral (mg/kg) | <5 | 5 ~ 50 | 51 ~ 300 | 301 ~ 2000 | 2001 ~ 5000 |
Comparison of acute toxicity results between iUDP and mKM in three alkaloids
| Method | Compound | Category | Animals | Compound (g) | Expense (MOP) | Duration (Day) |
|---|---|---|---|---|---|---|
| iUDP | Nicotine | II | 7 | 0.0082 | 1330 | 21 |
| Sinomenine hydrochloride | IV | 7 | 0.114 | 1330 | 21 | |
| Berberine hydrochloride | V | 9 | 1.9 | 1900 | 24 | |
| mKM | Nicotine | II | 74 | 0.0673 | 14,060 | 14 |
| Sinomenine hydrochloride | IV | 80 | 1.24 | 15,200 | 14 | |
| Berberine hydrochloride | V | 86 | 12.7 | 16,340 | 14 |